Landstrom, Andrew P <br/><br/>
Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome.  [electronic resource] 

 -  Leukemia & lymphoma  Nov 2007 
 - 2137-40 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190701618284  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Chromosome Aberrations<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis<br/>Male<br/>Middle Aged<br/>Mosaicism--drug effects<br/>Philadelphia Chromosome<br/>Piperazines--therapeutic use<br/>Prognosis<br/>Pyrimidines--therapeutic use<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome